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1. Introduction 
Depression has a substantial impact on the lives of patients and their families, significantly 
affecting their social and occupational lives as well as causing other functional impairments 
(Murray & Lopez, 1996). 
The objective of this chapter is to present the use of cognitive-behavioral therapy (CBT) in 
patients with depression by describing the techniques used and the efficacy of this 
therapeutic strategy. To achieve this aim, a search was accomplished to identify the 
principal relevant clinical trials by conducting a non-systematic literature review using the 
Medline, SciELO and PsychInfo databases, supplemented with textbooks on the subject. A 
description of the CBT model is followed by a discussion on efficacy studies. 
2. Epidemiological aspects 
Major depressive episode (MDE) is one of the most prevalent psychiatric disorders. A study 
carried out in the United States using the DSM-IV (American Psychiatric Association, 1996) 
criteria reported lifetime prevalence of 16.2%, and 12-month prevalence of 6.6% (Kessler et 
al., 2003). 
For many patients, the disorder is chronic and recurrent. Follow-up studies have shown that 
up to 30% of patients remain depressed after one year, 18% after two years and 12% after 
five years. Many treated patients retain residual and subsyndromal symptoms that are 
associated with unfavorable outcomes such as higher risk of recurrence and suicide, poorer 
psychosocial functioning and elevated mortality resulting from clinical diseases. Of the 
patients who recover from a depressive episode, more than 50% relapse (Kennedy et al., 
2004). The return of depressive symptoms during maintenance therapy with antidepressants 
occurs at rates that vary from 9 to 57% (Byrne & Rothschild, 1998). 
The greatest concern in the follow-up of these patients is suicide, which is significantly 
associated with major depression. Based on the results of a meta-analysis, the estimated risk 
                                                 
*This chapter is an update of Powell et al.’s (2008) article. 
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of suicide was 2.2% in less severe outpatients and 8.6% in those with more severe depression 
and a history of hospitalization (Bostwick & Pankratz, 2000). Because of its high prevalence 
and resulting disability (major depression is classified as the second greatest cause of 
disability, adjusted for years of life, in developed countries) (Murray & Lopez, 1996). The 
concern in preventing recurrences of MDE is relevant and has been the target of research 
both with pharmacological treatment and psychotherapy (Antonuccio et al., 1995; Fava et 
al., 1996; Fava et al., 1998a; Fava et al., 1998b; Hollon et al., 2005). 
3. The cognitive model and depression 
In the 1960s, Albert Ellis and Aaron Beck reached the important conclusion that depression 
was the result of extremely deeply established thought habits, and described the 
fundamental concepts of cognitive-behavioral therapy. Beck (1963; 1967) observed that 
negative moods and behavior were usually the result of distorted thoughts and beliefs and 
not of unconscious forces, as the Freudian theory suggested. In other words, depression may 
be understood as being the result of the patient's own cognitions and dysfunctional 
cognitive strategies. Patients with depression believe and act as if things were worse than 
they really are. This new treatment approach emphasizing thought was referred to by Beck 
as cognitive therapy (Beck, 1963). To this date, more than 300 controlled clinical trials have 
confirmed the efficacy of this therapy, which makes it the psychotherapeutic option with the 
greatest empirical support (Beck, 2005; Butler et al., 2006). 
As developed by Aaron T. Beck, cognitive behavioral therapy (CBT) for depression is 
currently the best-researched therapeutic strategy for any psychological disorder (Beck, 
2005). Many studies and meta-analyses have confirmed its efficacy for the treatment of mild, 
moderate or severe depression. Furthermore, CBT is at least as effective as pharmacological 
therapy or any other form of psychological intervention [e.g. interpersonal therapy (IPT) or 
supportive treatment] (Dobson, 1989). An additional benefit of CBT has been recorded in 
many treatment studies; it results in a more durable response compared to drug therapy and 
may be protective against recurrence (Hollon et al., 2005; Hollon et al., 1991). 
4. Cognitive triad 
Beck's cognitive theory of depression assumes two basic elements: the cognitive triad and 
cognitive distortions (Beck, 1963). The cognitive triad consists of a negative vision of oneself 
in which the person tends to see him/herself as inadequate or inept (e.g. "I am a boring 
person", "I am uninteresting", "I am too sad for anyone to like me"), a negative view of the world, 
including relationships, work and activities (e.g. "No one appreciates my job") and a negative 
view of the future, which appears to be cognitively linked to the degree of hopelessness. The 
most typical thoughts and verbal expressions with respect to a negative view of the future 
include: "Things are never going to get any better", "I will never be worth anything" or "I'll never be 
happy". Such thoughts, when coupled with hopelessness and suicidal ideation may make 
death seem like a relief from psychological pain or suffering or an escape from a situation 
perceived to be unbearable (Beck, 1976). 
Beck et al. (1979) observed that the depressed patients describe their experience negatively 
and expect unfavorable outcomes to occur. This manner of interpreting events and 
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expectations makes inactivity and inertia seem logical, which in turn, serves to reinforce the 
depressed person’s feelings of inadequacy, low self-esteem and hopelessness. 
5. Cognitive distortions 
Cognitive distortions, defined as systematic errors in the perception and processing of 
information, occupy a central role in depression. Individuals with depression tend to be 
absolute and inflexible in structuring their experiences, leading to errors of interpretation 
with regard to personal performance and judgment of external situations (J. S. Beck 1995; 
Scher et al., 2006). 
The most common cognitive distortions in depressed patients were classified by Beck et al. 
(1979) into a typological system that includes, among others, arbitrary inference 
(formulating a conclusion in the absence of sufficient evidence), selective abstraction 
(tendency of the person to select proof of his/her poor performance), overgeneralization 
(tendency to consider that one negative event or performance will occur other times), and 
personalization (personal attribution, often negative). A larger series of distortions has been 
described by Beck and others (Beck et al., 1979; Scher et al., 2006). Recently, de-Oliveira 
(chapter 1) developed the Cognitive Distortions Questionnaire (CD-Quest), a questionnaire 
to help therapist and patient to assess and follow changes in cognitive distortions frequency 
and intensity during therapy. 
Cognitive distortions logically follow the patient’s internal rules and assumptions, which are 
stable patterns of thinking developed throughout the lifetime of every individual. These 
rules and beliefs are sensitive to activation by primary sources such as stress or losses and 
often lead to ineffective interpersonal strategies (Scher et al., 2006). 
6. Use of cognitive therapy in depression 
Cognitive therapy for depression is a treatment process that helps patients alter beliefs and 
behaviors that produce certain mood states. The therapeutic strategies of cognitive-
behavioral management of depression occur in three phases: 1) education, forming the 
therapeutic relationship and making behavioral changes to confront problems with poor 
self-care and vegetative symptoms; 2) focus on automatic thoughts; and 3) focus on 
dysfunctional core beliefs. 
One of the advantages of cognitive therapy is the way in which patients actively participate 
in their own treatment, helping them to: a) identify distorted perceptions; b) recognize 
negative thoughts and seek alternative thoughts that more closely reflect reality; c) find 
evidence supporting negative and alternative thoughts; and d) generate more believable and 
accurate thoughts associated with certain situations in a process called cognitive 
restructuring; d) behave in more functional ways; and e) manage life problems more 
effectively (Beck, 1979). 
7. Behavioral activation 
One of the theories that guides the procedures involved in the treatment of depression is 
Lewinsohn's (1974, 1975) theory that social learning and the level of positive reinforcement 
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are factors that contribute towards the onset and maintenance of depressive states. This 
theory states that patients become depressed because they are experiencing a decrease in the 
general reinforcement they receive from the outside world – as a result of a decreased 
positive reinforcement and/or an excess of aversive experiences. Depression is conceived in 
this model as a vicious circle in which the patient gradually withdraws from positive 
activities and experiences the exponential loss of positive reinforcement. Therefore, the 
therapist must work incisively to increase the involvement of depressed patients in activities 
that should result in positive reinforcement and social interaction. 
The behavioral strategies used in CBT originate from Lewinsohn's (1974, 1975) model of 
psychopathology and are used flexibly. These strategies are planned in accordance with 
each individual patient and are used in such a way as to engage the patient, relieve 
symptoms and obtain information that is relevant to therapy. 
The initial strategy, consisting of the scheduling and monitoring of activities, is a 
powerful tool to be used by patients with depression. In fact, some patients with 
depression may respond to behavioral activation alone (Dimidjian et al., 2006). The 
scheduling of activities may be used flexibly by clinicians and patients to monitor 
activities (to correct distortions in the way patients think they are spending their time and 
to evaluate activities associated with control and pleasure), to schedule enjoyable 
activities and productive activities (particularly for depressed patients who do not allow 
themselves to participate in these activities) and to identify activities related to very 
positive or very negative feelings. This technique provides the patient and the therapist 
with data on how the patient is functioning. Scheduling of activities may be used to plan 
behavioral tasks and to record results. Acting according to a plan rather than waiting for a 
“feeling” is much more effective for depressed patients. Moreover, this procedure gives 
patients control over their time, recognizes their efforts with respect to performing 
activities and records true accomplishments. This technique is a powerful tool to be used 
with patients under pharmacological treatment, since it will give them the opportunity to 
record side effects, activities and changes in symptoms. This relatively simple 
intervention can illustrate the relationship between depressive symptoms and lack of 
intentional, positive behaviors, thereby opening a pathway towards solving problems 
(Beck et al., 1979). 
In CBT, skill deficits are also conceptualized as factors that may contribute to the risk for 
depression. For example, if the individual is unable to be assertive in interpersonal 
relationships, he/she misses out on an important opportunity for positive reinforcement. 
One significant contribution of Beck and other investigators to this model is the idea that, 
besides the reduction in positive reinforcement, depressed patients also increase the 
magnitude of their symptoms through the cognitive evaluations and conclusions that they 
reach from the lack of positive reinforcement. For example, depressed patients carry out 
fewer and fewer activities and conclude that it is hopeless to try and do anything. When 
therapists help patients modify this behavior, this brings direct evidence that their 
cognitive evaluations are incorrect. Patients then have a powerful example of how errors 
in their way of thinking have led to dysfunctional emotions and behavioral responses, 
and the treatment advances by cognitive and behavioral means to solving problems 
(Sudak, 2006). 
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8. Cognitive restructuring 
The initial sessions are also directed towards defining the patients' problems by elaborating 
the conceptualization or formulation of the case. In these sessions, therapists will help 
patients identify: 1) the particular dysfunctional beliefs they have associated with 
depression; 2) their most common cognitive distortions and classification of automatic 
thoughts; 3) the physiological, emotional and behavioral reactions arising from these 
thoughts; 4) behaviors that were developed to confront dysfunctional beliefs; and 5) how 
previous experiences have contributed towards maintaining the patients' beliefs (J. S. Beck, 
1995). 
8.1 Evoking thoughts and assumptions 
Depression generates immobility and pessimism; therefore, patients find it difficult to begin 
any task and fail to identify any advantage in performing any activity. An initial step in 
treating patients, following behavioral activation is to help the patient to identify such 
thoughts. 
Of note, the goal of cognitive therapy in MDE is to facilitate the remission of depression and 
to teach patients to be their own therapists. Cognitive techniques should help achieve the 
objectives of therapy and should be understood by the patient as tools that they can use in 
the future. Patients should be stimulated to confront the problems related to mood 
complaints and therapists should not help them with each problem, since this may prevent 
strengthening their own abilities (Beck et al., 1979). An extensive series of cognitive 
techniques and the discussion of their applications may be found in Leahy's excellent 
textbook (Leahy, 2003). Some of the techniques that have proven more effective in the 
treatment of MDE are presented below. 
8.2 Explanation on how thoughts are related to feelings 
A direct question by the therapist such as "what were you thinking about at that moment?" or 
"what went through your mind right now?" when the patient exhibits a shift in emotion or 
relays an emotionally-laden situation, may be supplemented by a table with two parallel 
columns describing: 1) I think that …; and 2) Hence, I feel… When the therapist uses this 
type of resource, difficulties may arise for the patient to correctly identify thoughts and 
feelings, and the therapist's help may be necessary (Leahy, 2003). 
8.3 Recording dysfunctional thoughts 
This technique increases objectivity and encourages the individual to remember events, 
thoughts and feelings that occurred between sessions. Generally, the individual needs 
training to use this daily thought diary, initially being able to identify automatic thoughts by 
first identifying emotional states. The tool comprises a register in which the patient writes 
down sequentially an event and the subsequent thought that occurs at a time of problematic 
emotions or behaviors. There is an additional column to give a note related to what extent 
the patient believes that thought is true. This column will progressively help the individual 
identify which dysfunctional automatic thoughts are most likely to be a productive focus of 
attention. Next, the emotion is recorded and the degree of emotion is evaluated on a 0-10 or 
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0-100 scale. To help the patient, comparison may be made with the most intense emotion 
(sadness, for example) in order to reach a more realistic evaluation (Beck et al., 1979). 
Thought records also include an evidence-gathering column, and a column to generate an 
alternative thought about the situation. Finally, the patient is asked to rate the believability 
of the new thought as well as to rate the intensity of the emotion (Padesky & Greenberger, 
1995). 
8.4 Trial-Based Thought Record (TBTR) 
De Oliveira (2008) has developed the TBTR, a 7-column thought record designed to address 
core beliefs by means of sentence-reversion and the analogy to a judicial process. This 
method might be useful in restructuring negative beliefs in depressed patients. Despite the 
lack of clinical trials comparing this method with other psychological approaches used to 
treat depression, case reports indicate its potential in this regard. The inspiration for its 
development came from the surreal novel by Franz Kafka, The Trial (Kafka, 1998; first 
published in 1925). The rational basis to propose the TBTR is that it could be useful to make 
patients aware of their core beliefs about themselves (self-accusations) and engage them in a 
constructive trial to develop more positive and functional core beliefs (De-Oliveira, 2011). 
TBTR incorporates a structured format and sequentially presents several techniques already 
used in conventional cognitive therapy: downward arrow technique, examining the 
evidence, defense attorney technique, thought reversal, upward arrow technique, 
developing a more positive schema, and positive self-statement logs, and the empty chair 
approach (see chapter 3 in this book). 
8.5 Downward arrow 
As patients become more capable of identifying and restructuring automatic thoughts, it is 
important to investigate the underlying beliefs that lead to such thoughts, and make the 
person vulnerable to negative events. Changing such beliefs increases the durability of 
recovery from depression (DeRubeis et al., 1990; Hollon et al., 1990).  
A form of Socratic questioning called downward arrow can be used to help identify such 
beliefs about the self and others (Burns, 1980; De-Oliveira, 2011). The Socratic method is also 
used to help the patient develop autonomous reasoning to question the evidence and create 
alternative thoughts and evaluations. Confronting the evidence of thoughts may help 
patients reduce the power of the thought, decreasing their feelings of fear, sadness or 
discouragement. The downward arrow is a very useful technique that helps to oppose 
beliefs that maintain the state of depression. 
9. The duration of treatment and remission of symptoms 
Although patients with axis 2 co-morbidity or significant anxiety symptoms associated with 
depression may require longer treatment with cognitive therapy, this therapy normally is 
short-term (Blenkiron, 1999). Structured sessions also help patients develop a sense of 
personal control and enhance the efficiency of treatment. Patients with personality disorders 
may require more time in therapy, even more than 12 months (Byrne & Rothschild, 1998). 
Often, these patients tend to drop out from treatment more easily and the therapist should 
be attuned to the therapeutic alliance. Some research has indicated the patients with Axis 2 
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disorders who cannot receive longer courses of CBT might benefit more from managing 
symptoms with medication (Fournier et al., 2008), or behavioral activation (Coffman et al., 
2007).  
In addition, the therapist should also be attentive that patients may drop out or interrupt 
their treatment following the remission of the first symptoms that had previously 
maintained them less active and less confident. As these symptoms improve, there may be a 
tendency to drop out treatment prematurely. 
10. Prevention of relapses 
The final sessions are aimed at evaluating the advances made in therapy and at preventing 
recurrences. The patient's improvement may be used as a resource for confronting new 
situations that include losses and adaptations to current problems. From the beginning, it 
should be emphasized that the duration of therapy is limited; the procedures involved in 
therapy should be demystified by relating them to the identification of thoughts, their 
questioning and restructuring; the patients' confidence should be increased based on their 
gains; and, gradually patients increase their role in the process of change. All these 
procedures facilitate progress towards the termination of therapy and generate confidence 
in patients to proceed with their lives. The therapist must teach patients to deal with the 
possibility of a recurrence of depressive symptoms, since depression is a highly recurrent 
disorder (Deckrsbach et al., 2000).Therefore, another important strength of cognitive therapy 
is its durability in recurrent unipolar depression, as compared to pharmacological 
treatments (Fava et al., 1998). 
Fava et al. (1996) suggested that cognitive therapy for the residual symptoms of a depressive 
episode treated with medication leads to substantially fewer recurrences. In a preliminary 
study involving 40 patients, those with recurrent major depression who had been 
successively treated with antidepressants were randomly allocated into two groups, one 
treated with cognitive therapy for the residual symptoms and the other with conventional 
clinical management. After 20 weeks of treatment, the administration of antidepressants was 
reduced and then ceased in both groups. Patients were followed up for two years during 
which no medication was used except for cases of recurrence. The group in which cognitive 
therapy was given was found to have significantly fewer residual symptoms compared to 
the group that received conventional clinical management. Cognitive therapy also resulted 
in lower recurrence rates (25%) compared to clinical management (80%). 
Data referring to the patients of the above-mentioned study were published after 4 and 6 
years of follow-up (Fava et al., 1998a; Fava et al., 1998b). Treatment with cognitive therapy 
resulted in a significant reduction in recurrence rates at 4 years (35% versus 70%) (Fava  
et al., 1998a). After 6 years of follow-up (Fava et al., 1998b), 10 of the patients in the cognitive 
therapy group (50%) and 15 of the patients in conventional treatment (75%) had suffered 
relapses; however, this difference was not statistically significant. When multiple 
recurrences were considered, the patients submitted to cognitive therapy had significantly 
fewer episodes and responded to the same antidepressant used in the basal episode of the 
study. The authors concluded that cognitive therapy seems to offer a protective effect for up 
to four years of follow-up, and this effect becomes weaker afterwards. Nevertheless, 
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cognitive therapy for the residual symptoms led to a long-term reduction in the number of 
episodes of major depression (Fava et al., 1998a). According to Fava et al. (1998b), these 
results challenge the established belief that prolonged pharmacological treatment is the only 
way of preventing relapses in patients with recurrent depression. 
However, in what way would CBT prevent recurrences in patients with MDE? One 
proposal denominated "metacognitive awareness" may explain this phenomenon. Instead of 
considering the modification of dysfunctional beliefs as a tool for preventing recurrences, 
the metacognitive awareness approach suggests that the negative thoughts and feelings in 
MDE are experienced as mental events and not as an expression of reality. As patients 
evolve in their depressive state, they cease to automatically accept the negative thoughts. 
This hypothesis, still under investigation, seems useful as an explanation for the success 
achieved with cognitive therapy in the prevention of recurrences. 
Another study (Murphy et al., 1984) followed patients with MDE for two years. Patients 
who had had a mean of three episodes of moderate to severe MDE were divided into three 
treatment groups: 1) antidepressants (AD); 2) CBT with monthly maintenance; and 3) AD in 
the acute phase plus CBT with monthly maintenance. Patients were distributed as follows: 
AD: 31%; monthly CBT: 36%; AD + monthly CBT: 24%. At the end of 24 months, there was 
no statistically significant difference in recurrence rates. This study showed that cognitive 
therapy was at least as effective as AD in maintaining remission and preventing relapses. 
Maintenance pharmacotherapy may be necessary for some patients while cognitive therapy 
is a viable alternative for others. 
11. Cognitive therapy and pharmacotherapy 
The first study on CBT for depression was published in 1977 (Rush et al., 1977). The authors 
compared CBT to imipramine and reported significantly better results with CBT. This study 
was not, however, placebo controlled. Another significant limitation was that the research 
team was not blinded with respect to the form of treatment, so further investigation was 
necessary to confirm efficacy. By 1989, a sufficient number of studies had been performed to 
allow a review and meta-analysis to be carried out (Dobson, 1989). Twenty-eight studies 
were included in that sample, which found better results for CBT compared to medication 
and other psychological treatments. In subsequent years, various studies confirmed the 
significant efficacy of CBT in the treatment of major depression and its increased durability 
compared to pharmacological therapy. The sole exception to this was the NIMH's Treatment 
of Depression Collaborative Research Project (TDCRP), a large, multi-centered trial of CBT 
versus IPT versus medication (imipramine) versus placebo. CBT performed as well as 
IPT/imipramine in cases of mild to moderate depression, but in cases of more severe 
depression, IPT and imipramine gave better results (Elkin et al., 1989). Further analysis 
carried out by DeRubeis et al. (1999) on the data from this study indicated that there were 
significant differences in the efficacy of CBT across sites. In Philadelphia, where therapist 
fidelity to the model was more robust, CBT performed as well as IPT or medication. 
DeRubeis and Feeley subsequently studied therapist fidelity to the model and found that 
therapist fidelity early in treatment is predictive of patient response in depression. 
Following TDCRP (Elkin et al., 1989), a significant number of studies went on to expand the 
empirical basis for the use of CBT in acute and chronic depression, both alone and in 
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combination with medication (Jarrett et al., 1999; Hollon et al., 1992). Many studies 
evaluating efficacy were conducted in order to establish CBT as being at least as effective as 
or superior to a pharmacological intervention. Greenberg and Fisher (1997, 1989) described a 
number of well-conducted clinical trials comparing active and directive psychotherapies 
(such as cognitive and interpersonal therapies) with antidepressants and suggested that 
outpatients submitted to psychotherapy evolved just as well or at times better than those 
receiving medication. They also concluded that, although medication improved sleep-
related symptoms, psychotherapy was more effective in helping patients with depression 
and apathy. Moreover, unlike psychotherapy, medication was unable to help depressed 
outpatients to adjust socially, and to recover their interpersonal relationships and their 
professional performance (De-Oliveira, 1998). 
Systematic reviews and meta-analyses have noted that CBT has efficacy similar to that of 
antidepressant treatment (Dobson, 1989; Hollon et al., 1991; Conte et al., 1986; Robinson et 
al., 1990; Wexler & Cicchetti, 1992). Treatment with psychotherapy also conveyed an 
advantage with respect to dropout rates and recurrences (de Jonghe, 2001). Another large 
clinical trial (Keller et al., 2000) was conducted with 681 patients with chronic and recurrent 
major nonpsychotic depression, and compared nefazodone, cognitive behavioral-analysis 
system of psychotherapy (a recently developed form of cognitive therapy), and the 
combination thereof. A total of 16-20 sessions were conducted over 12 weeks. Taking into 
consideration only patients who completed the study, remission or a satisfactory response 
was achieved in 85% of cases in the group that received the combined treatment and in 55% 
of cases in the group treated with nefazodone or therapy alone. 
Most combined treatment studies accomplished to date are heterogeneous regarding the 
medications evaluated and did not employ adequate pharmacotherapy as implemented in 
clinical practice; hence, it is difficult to draw adequate conclusions with respect to the added 
benefits of combined treatment versus the use of either modality alone. Nevertheless, 
several reviews and one interesting meta-analysis indicate that in cases of more severe 
depression there may be a significant added benefit with the combined use of medication 
and cognitive behavioral treatments (Hollon et al., 1991; Friedman et al., 2006). Several 
studies have been conducted to counter the objections raised about data acquired in earlier 
studies of CBT for depression. Most impressively, DeRubeis et al. (2005) published a 
definitive study comparing CBT to medication, which included a placebo control group and 
an augmentation protocol for non-responders to the initial study medication. This study 
included patients who were moderately to severely depressed, and who had co-morbid 
anxiety and personality disorders. CBT and medication performed equally well for the acute 
treatment of moderate to severe depression. 
As previously discussed, the most impressive finding in studies of CBT for depression is the 
durability of its effect. Patients who are CBT responders have a significantly more durable 
response than patients whose depression is treated with medication. Many recent reviews 
describe substantial decrement in response to antidepressant medication even if the patient 
continues taking the medication properly, an event that occurs only 26% of the time 
(Bockting et al., 2008). 
Recurrence of major depression is common. Several studies have attempted to forestall this 
recurrence by employing novel strategies in CBT. Jarrett et al. (1999) have shown that 
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booster sessions of CBT have a substantial effect on the recurrence of depression in chronic 
patients who are CBT responders. Several studies have evaluated the sequential treatment 
with medication and CBT using a brief CBT protocol applied either individually or in 
groups following treatment with medication, including Fava's studies previously described 
(Fava et al., 1998a; Fava et al., 1998b; Fava et al., 1998; Bockting et al., 2008 and Paykel et al. 
(1999) achieved similarly impressive results using individual and group treatment strategies 
with a very short-term treatment protocol. Mindfulness-based cognitive therapy has also 
been successfully used in chronic depression to forestall recurrence after successful 
remission has been achieved (Teasdale et al., 2000). 
In conclusion, CBT in the treatment of depression is one of the therapeutic alternatives with 
the highest empirical evidence of efficacy, whether applied alone or in combination with 
pharmacotherapy. 
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